Additionally, the report highlights the termination of the Option Care Health, Inc. ("OPCH") Merger Agreement and the ...

Gain insights into Chemed Corporation's Q1 2025 performance, with VITAS growth, strategic Medicare Cap solutions, and Roto-Rooter's revenue recovery outlined.

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

U.S. crude oil inventories rose for a fourth consecutive week amid higher net imports, while refineries ramped up their capacity use. Commercial crude oil stocks excluding the Strategic Petroleum ...

In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) ...

Headwinds primarily associated with Medicare Advantage (MA) and care activity in its insurance business led UnitedHealth Group (UHG) (NYSE: UNH) to lower ...

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Department of Justice will head to mediation with UnitedHealth Group and Amedisys April 18 as part of an ongoing antitrust lawsuit. Both companies are attempting to finalize a $3.3 billion ...

The Justice Department’s antitrust lawsuit aimed at blocking UnitedHealth Group’s $3.3 billion acquisition of Amedisys will go to mediation on Aug. 18. Magistrate Judge Susan Gauvey of the ...

Stock markets surged in response after several days of significant declines. Business leaders across the spectrum, from Bill Ackman to Mark Cuban, reacted disparately. President Donald Trump on ...